Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FY5XR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,487
Award facts
- Contract value 100% obligated
- $43,486.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $43,486.92 for the supply of Renflexis 100 mg vials on June 9, 2025, with an ultimate completion date of June 10, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive pharmaceutical portfolio. The company maintains an extensive contract history with the Defense Logistics Agency, fulfilling diverse medical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Renflexis—a biosimilar to Remicade used for treating inflammatory conditions—exemplifies the company's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through the flexible pharmaceutical prime vendor contract framework.
Quick answers
Who was awarded contract SPE2DB25FY5XR?
SPE2DB25FY5XR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 9, 2025.
How much is contract SPE2DB25FY5XR worth?
The government has obligated $43,487 on SPE2DB25FY5XR.
Is contract SPE2DB25FY5XR an order under another contract?
Yes. SPE2DB25FY5XR is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY5XR competed?
The extent of competition for SPE2DB25FY5XR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award